KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,535,747 | +2.3% | 616,169 | +3.8% | 0.48% | +10.3% |
| Q4 2022 | $7,366,092 | -3.3% | 593,561 | +9.1% | 0.44% | -1.8% |
| Q4 2021 | $7,618,000 | -46.1% | 544,173 | -27.9% | 0.44% | -46.9% |
| Q3 2021 | $14,143,000 | +52.6% | 755,121 | +69.9% | 0.84% | +56.9% |
| Q2 2021 | $9,265,000 | +294.1% | 444,372 | +434.3% | 0.53% | +278.7% |
| Q1 2021 | $2,351,000 | -40.3% | 83,164 | -31.1% | 0.14% | -40.0% |
| Q4 2020 | $3,941,000 | -42.9% | 120,677 | -46.4% | 0.24% | -54.1% |
| Q3 2020 | $6,902,000 | -30.7% | 225,259 | -63.1% | 0.51% | -18.5% |
| Q2 2020 | $9,959,000 | +130.1% | 610,979 | +147.0% | 0.63% | +62.7% |
| Q3 2018 | $4,329,000 | +28.4% | 247,385 | +33.6% | 0.39% | +79.5% |
| Q2 2018 | $3,371,000 | – | 185,195 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |